戻る Agenda
Session 8: Updates from Health Authorities
Session Chair(s)
Frank Montgomery, PhD
Global Head Regulatory CMC, GRAPSQA
AstraZeneca, United Kingdom
This session features regulatory updates from members of national, regional and global health associations sharing recent trends and changes anticipated for the future. The session will allow discussion on the evolving global regulatory environment.
Speaker(s)
Sabine Kopp, PhD
World Health Organization (WHO), Switzerland
Group Lead, Medicines Quality Assurance
Peter Richardson, PhD
European Medicines Agency, Netherlands
Head of Quality, Specialised Scientific Disciplines Department
Ingo Matthes, PhD
Swissmedic, Swiss Agency for Therapeutic Products, Switzerland
Head of Division Quality Review/Sector Marketing Authorisation
Mihaela Buda, PhD
European Directorate for the Quality of Medicines & HealthCare (EDQM), France
Scientific Programme Manager, European Pharmacopoeia Department